{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:12:29Z","timestamp":1788567149061,"version":"build-2803163510"},"reference-count":114,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Current research on hypertension utilizes more than fifty animal models that rely mainly on stable increases in systolic blood pressure. In experimental hypertension, grading or scoring of glomerulopathy in the majority of studies is based on a wide range of opinion-based histological changes that do not necessarily comply with lesional descriptors for glomerular injury that are well-established in clinical pathology. Here, we provide a critical appraisal of experimental hypertensive glomerulopathy with the same approach used to assess hypertensive glomerulopathy in humans. Four hypertensive models with varying pathogenesis were analyzed\u2013chronic angiotensin II infused mice, mice expressing active human renin in the liver (TTRhRen), spontaneously hypertensive rats (SHR), and Goldblatt two-kidney one-clip rats (2K1C). Analysis of glomerulopathy utilized the same criteria applied in humans\u2013hyalinosis, focal segmental glomerulosclerosis (FSGS), ischemic, hypertrophic and solidified glomeruli, or global glomerulosclerosis (GGS). Data from animal models were compared to human reference values. Kidneys in TTRhRen mice, SHR and the nonclipped kidneys in 2K1C rats had no sign of hyalinosis, FSGS or GGS. Glomerulopathy in these groups was limited to variations in mesangial and capillary compartment volumes, with mild increases in collagen deposition. Histopathology in angiotensin II infused mice corresponded to mesangioproliferative glomerulonephritis, but not hypertensive glomerulosclerosis. The number of nephrons was significantly reduced in TTRhRen mice and SHR, but did not correlate with severity of glomerulopathy. The most substantial human-like glomerulosclerotic lesions, including FSGS, ischemic obsolescent glomeruli and GGS, were found in the clipped kidneys of 2K1C rats. The comparison of affected kidneys to healthy control in animals produces lesion values that are numerically impressive but correspond to mild damage if compared to humans. Animal studies should be standardized by employing the criteria and classifications established in human pathology to make experimental and human data fully comparable for comprehensive analysis and model improvements.<\/jats:p>","DOI":"10.1371\/journal.pone.0264136","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T18:44:56Z","timestamp":1645123496000},"page":"e0264136","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Comparative analysis of hypertensive nephrosclerosis in animal models of hypertension and its relevance to human pathology. Glomerulopathy"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6251-1338","authenticated-orcid":true,"given":"Alex A.","family":"Gutsol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taben M.","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Francois","family":"Thibodeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chet E.","family":"Holterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania","family":"Nasrallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9580-3361","authenticated-orcid":true,"given":"Jose W. N.","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey A.","family":"Afanasiev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhian M.","family":"Touyz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris R. J.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"H\u00e9bert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"pone.0264136.ref001","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1016\/S0140-6736(16)31134-5","article-title":"A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension","volume":"388","author":"MH Olsen","year":"2016","journal-title":"Lancet"},{"key":"pone.0264136.ref002","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.mcna.2004.11.006","article-title":"Epidemiology and risk factors for chronic kidney disease.","volume":"89","author":"WM McClellan","year":"2005","journal-title":"Med Clin North Am"},{"key":"pone.0264136.ref003","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3389\/fimmu.2015.00465","article-title":"Animal models to study links between cardiovascular disease and renal failure and their relevance to human pathology.","volume":"6","author":"TD Hewitson","year":"2015","journal-title":"Front. Immunol"},{"key":"pone.0264136.ref004","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1681\/ASN.2009070721","article-title":"Mouse models of diabetic dephropathy","volume":"20","author":"FC Brosius","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"pone.0264136.ref005","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/MNH.0b013e3283451901","article-title":"Mouse models of diabetic nephropathy.","volume":"20","author":"CE Alpers","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"pone.0264136.ref006","first-page":"17","article-title":"New targets for treatment of diabetic nephropathy: what we have learned from animal models.","volume":"22","author":"FC Brosius","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"pone.0264136.ref007","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s00125-016-3916-5","article-title":"PGE2 receptor EP3 inhibits water reabsorption and contributes to polyuria and kidney injury in a streptozotocin-induced mouse model of diabetes","volume":"59","author":"R Hassouneh","year":"2016","journal-title":"Diabetologia"},{"key":"pone.0264136.ref008","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/ndt\/gfx219","article-title":"The diabetes pandemic suggests unmet needs for \u201cCKD with diabetes\u201d in addition to \u2018diabetic nephropathy\u2019- implications for pre-clinical research and drug testing.","volume":"33","author":"LA G\u00f3mez","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"pone.0264136.ref009","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.lab.2005.05.005","article-title":"Animal models of hypertension: An overview","volume":"146","author":"LO Lerman","year":"2005","journal-title":"J Lab Clin Med"},{"key":"pone.0264136.ref010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ddmod.2009.03.003","article-title":"Rat as a model system for hypertension drug discovery","volume":"5","author":"VLM Herrera","year":"2008","journal-title":"Drug Discov Today Dis Model"},{"key":"pone.0264136.ref011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/528757","article-title":"Animal models in cardiovascular research: hypertension and atherosclerosis","volume":"2015","author":"X-F Leong","year":"2015","journal-title":"Biomed Res Int"},{"key":"pone.0264136.ref012","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/ki.1994.290","article-title":"Calcium blockade versus ACE inhibition in clipped and unclipped kidneys of 2K-1C rats","volume":"46","author":"M V\u00e9niant","year":"1994","journal-title":"Kidney Int"},{"key":"pone.0264136.ref013","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/labinvest.3700383","article-title":"Renoprotective effect of a dopamine D3 receptor antagonist in experimental type II diabetes","volume":"86","author":"MLP Gross","year":"2006","journal-title":"Lab Investig"},{"key":"pone.0264136.ref014","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/hr.2012.2","article-title":"Short-term ACE inhibition confers long-term protection against target organ damage.","volume":"35","author":"TM Hale","year":"2012","journal-title":"Hypertens Res"},{"key":"pone.0264136.ref015","doi-asserted-by":"crossref","first-page":"e0117899","DOI":"10.1371\/journal.pone.0117899","article-title":"Loss of prolyl carboxypeptidase in two-kidney, one-clip goldblatt hypertensive mice.","volume":"10","author":"N Grobe","year":"2015","journal-title":"PLoS One"},{"key":"pone.0264136.ref016","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1172\/JCI200317647","article-title":"JunD protects against chronic kidney disease by regulating paracrine mitogens","volume":"112","author":"E Pillebout","year":"2003","journal-title":"J Clin Invest"},{"key":"pone.0264136.ref017","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ajpath.2014.11.013","article-title":"The effect of angiotensin-(1\u20137) in mouse unilateral ureteral obstruction.","volume":"185","author":"DL Zimmerman","year":"2015","journal-title":"Am J Pathol"},{"key":"pone.0264136.ref018","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s10157-018-1552-8","article-title":"Recent advances of animal model of focal segmental glomerulosclerosis","volume":"22","author":"JW Yang","year":"2018","journal-title":"Clin. Exp. Nephrol"},{"key":"pone.0264136.ref019","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000329334","article-title":"Hypertensive cardiovascular and renal disease and target organ damage: lessons from animal models.","volume":"1","author":"D Susic","year":"2011","journal-title":"Cardiorenal Med"},{"key":"pone.0264136.ref020","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1093\/ndt\/gft071","article-title":"Animal models of chronic kidney disease: Useful but not perfect.","volume":"28","author":"GJ Becker","year":"2013","journal-title":"Nephrol. Dial. Transplant"},{"key":"pone.0264136.ref021","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1681\/ASN.2010010010","article-title":"Pathologic Classification of Diabetic Nephropathy","volume":"21","author":"TWC Tervaert","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"pone.0264136.ref022","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.path.2014.04.007","article-title":"Classification Systems in Renal Pathology","volume":"7","author":"MB Stokes","year":"2014","journal-title":"Surg Pathol Clin"},{"key":"pone.0264136.ref023","doi-asserted-by":"crossref","first-page":"14S","DOI":"10.1177\/0192623312438736","article-title":"Proliferative and nonproliferative lesions of the rat and mouse urinary system.","volume":"40","author":"KS Frazier","year":"2012","journal-title":"Toxicol Pathol."},{"key":"pone.0264136.ref024","volume-title":"Histopathology of preclinical toxicity studies.","author":"P. Greaves","year":"2012","edition":"4"},{"key":"pone.0264136.ref025","unstructured":"Kidney\u2014Nonneoplastic Lesion Atlas. https:\/\/ntp.niehs.nih.gov\/nnl\/urinary\/kidney\/index.htm"},{"key":"pone.0264136.ref026","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/HYPERTENSIONAHA.108.112706","article-title":"Role of inflammation in the development of renal damage and dysfunction in angiotensin II\u2013induced hypertension","volume":"52","author":"T-D Liao","year":"2008","journal-title":"Hypertension"},{"key":"pone.0264136.ref027","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/ki.1986.76","article-title":"Relation of glomerular injury to preglomerular resistance in experimental hypertension","volume":"29","author":"JL Olson","year":"1986","journal-title":"Kidney Int"},{"key":"pone.0264136.ref028","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/HJH.0b013e32835ba77e","article-title":"Angiotensin II-induced hypertension dose-dependently leads to oxidative stress and DNA damage in mouse kidneys and hearts","volume":"31","author":"S Brand","year":"2013","journal-title":"J Hypertens"},{"key":"pone.0264136.ref029","first-page":"725","article-title":"Long-term treatment with an ACE inhibitor or an AT1 antagonist avoids hypertension-induced inflammation in the kidney","volume":"19","author":"V Esteban","year":"2006","journal-title":"J Nephrol"},{"key":"pone.0264136.ref030","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1440-1681.1989.tb01615.x","article-title":"Comparison of the vascular and glomerular changes in aortic-ligature and DOCA-salt hypertension","volume":"16","author":"T Hewitson","year":"1989","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"pone.0264136.ref031","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/01.HYP.0000049881.25304.73","article-title":"Renoprotection by ACE inhibition or aldosterone blockade is blood pressure-dependent","volume":"41","author":"KA Griffin","year":"2003","journal-title":"Hypertension"},{"key":"pone.0264136.ref032","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1590\/S0102-86502007000100003","article-title":"Experimental model for the study of chronic renal ischemia in rats. Morphologic, histological and ultra-structural analysis.","volume":"22","author":"CL Konopka","year":"2007","journal-title":"Acta Cir Bras"},{"key":"pone.0264136.ref033","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1523-1755.1998.00019.x","article-title":"A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR).","volume":"54","author":"DJ Kelly","year":"1998","journal-title":"Kidney Int"},{"key":"pone.0264136.ref034","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ki.1991.175","article-title":"Role of growth hormone in the development of experimental renal scarring","volume":"40","author":"AM Nahas","year":"1991","journal-title":"Kidney Int"},{"key":"pone.0264136.ref035","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1469-7580.2005.00492.x","article-title":"A stereological study of the renal glomerular vasculature in the db\/db mouse model of diabetic nephropathy","volume":"207","author":"M Guo","year":"2005","journal-title":"J Anat"},{"key":"pone.0264136.ref036","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/HYPERTENSIONAHA.112.199919","article-title":"A mitochondrial permeability transition pore inhibitor improves renal outcomes after revascularization in experimental atherosclerotic renal artery stenosis","volume":"60","author":"A Eirin","year":"2012","journal-title":"Hypertens (Dallas, Tex 1979)"},{"key":"pone.0264136.ref037","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ki.1984.147","article-title":"Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats","volume":"26","author":"L Raij","year":"1984","journal-title":"Kidney Int"},{"key":"pone.0264136.ref038","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1023\/A:1020575001051","article-title":"Renal and myocardial histopathologic changes in two kidney\u2014One clip renovascular hypertenson.","volume":"33","author":"A G\u00f6zey","year":"2001","journal-title":"Int Urol Nephrol"},{"key":"pone.0264136.ref039","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/ki.1997.29","article-title":"Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans","volume":"51","author":"A Fogo","year":"1997","journal-title":"Kidney Int"},{"key":"pone.0264136.ref040","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/01.HYP.38.2.171","article-title":"Hypertensive nephrosclerosis as a relevant cause of chronic renal failure. Hypertens (Dallas, Tex 1979)","volume":"38","author":"ER Caetano","year":"2001","journal-title":"Hypertension"},{"key":"pone.0264136.ref041","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1681\/ASN.V131142","article-title":"Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy","volume":"13","author":"RI Ballardie FW","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"pone.0264136.ref042","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1053\/ajkd.2002.31980","article-title":"Glomerular size and glomerulosclerosis: relationships to disease categories, glomerular solidification, and ischemic obsolescence","volume":"39","author":"MD Hughson","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"pone.0264136.ref043","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1523-1755.2002.00420.x","article-title":"Hypertensive nephrosclerosis in African Americans versus Caucasians","volume":"62","author":"C Marcantoni","year":"2002","journal-title":"Kidney Int"},{"key":"pone.0264136.ref044","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/sj.ki.5000163","article-title":"Morphometric evidence for impairment of renal autoregulation in advanced essential hypertension","volume":"69","author":"GS Hill","year":"2006","journal-title":"Kidney Int"},{"key":"pone.0264136.ref045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1291\/hypres.29.15","article-title":"Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy","volume":"29","author":"R Ikee","year":"2006","journal-title":"Hypertens Res"},{"key":"pone.0264136.ref046","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1291\/hypres.30.635","article-title":"Effects of renin-angiotensin system blockade on macrophage infiltration in patients with hypertensive nephrosclerosis.","volume":"30","author":"T Imakiire","year":"2007","journal-title":"Hypertens Res"},{"key":"pone.0264136.ref047","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2369-13-139","article-title":"Renal arterial resistive index is associated with severe histological changes and poor renal outcome during chronic kidney disease.","volume":"13","author":"N Big\u00e9","year":"2012","journal-title":"BMC Nephrol."},{"key":"pone.0264136.ref048","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12882-016-0254-2","article-title":"Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: A retrospective cohort study.","volume":"17","author":"S Liang","year":"2016","journal-title":"BMC Nephrol"},{"key":"pone.0264136.ref049","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1681\/ASN.2016020154","article-title":"The substantial loss of nephrons in healthy human kidneys with aging","volume":"28","author":"A Denic","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"pone.0264136.ref050","doi-asserted-by":"crossref","first-page":"e0213981","DOI":"10.1371\/journal.pone.0213981","article-title":"p38 MAPK activity is associated with the histological degree of interstitial fibrosis in IgA nephropathy patients.","volume":"14","author":"J Lee","year":"2019","journal-title":"PLoS One"},{"key":"pone.0264136.ref051","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1159\/000485349","article-title":"KLF 15 works as an early anti-fibrotic transcriptional regulator in ang II-induced renal fibrosis via down-regulation of CTGF expression","volume":"42","author":"X Gu","year":"2017","journal-title":"Kidney Blood Press Res"},{"key":"pone.0264136.ref052","doi-asserted-by":"crossref","first-page":"F1295","DOI":"10.1152\/ajprenal.00471.2015","article-title":"Renovascular remodeling and renal injury after extended angiotensin II infusion","volume":"310","author":"FAM Casare","year":"2016","journal-title":"Am J Physiol Ren Physiol"},{"key":"pone.0264136.ref053","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYPERTENSIONAHA.109.139287","article-title":"Pressure-induced renal injury in angiotensin II versus norepinephrine-induced hypertensive rats","volume":"54","author":"AJ Polichnowski","year":"2009","journal-title":"Hypertension"},{"key":"pone.0264136.ref054","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.amjhyper.2006.05.019","article-title":"Cardiorenal protective effects of year-long antihypertensive therapy with a angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats","volume":"19","author":"T Ishimitsu","year":"2006","journal-title":"Am J Hypertens"},{"key":"pone.0264136.ref055","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/01.HYP.7.3_Pt_1.398","article-title":"Role of hypertension in progressive glomerular immune injury","volume":"7","author":"L Raij","year":"1985","journal-title":"Hypertension (Dallas, Tex 1979)"},{"key":"pone.0264136.ref056","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/01.HYP.21.6.975","article-title":"Angiotensin blockade and the progression of renal damage in the spontaneously hypertensive rat","volume":"21","author":"K Kohara","year":"1993","journal-title":"Hypertension"},{"key":"pone.0264136.ref057","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/hr.2016.93","article-title":"Attenuation of hypertension and renal damage in renovascular hypertensive rats by iron restriction","volume":"39","author":"M Oboshi","year":"2016","journal-title":"Hypertens Res"},{"key":"pone.0264136.ref058","doi-asserted-by":"crossref","first-page":"F278","DOI":"10.1152\/ajprenal.00419.2015","article-title":"Increased angiotensinogen expression, urinary angiotensinogen excretion, and tissue injury in nonclipped kidneys of two-kidney, one-clip hypertensive rats","volume":"311","author":"W Shao","year":"2016","journal-title":"Am J Physiol Ren Physiol"},{"key":"pone.0264136.ref059","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0022-2143(99)90006-9","article-title":"Angiotensin II receptor blockade limits kidney injury in two-kidney, one-clip Goldblatt hypertensive rats with special reference to phenotypic changes","volume":"133","author":"S Kobayashi","year":"1999","journal-title":"J Lab Clin Med"},{"key":"pone.0264136.ref060","doi-asserted-by":"crossref","first-page":"F876","DOI":"10.1152\/ajprenal.00174.2006","article-title":"Antihypertensive therapy induces compartment-specific chemokine expression and a Th1 immune response in the clipped kidney of Goldblatt hypertensive rats.","volume":"292","author":"OM Steinmetz","year":"2007","journal-title":"Am J Physiol\u2014Ren Physiol"},{"key":"pone.0264136.ref061","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/sj.ki.5000160","article-title":"Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants","volume":"69","author":"DB Thomas","year":"2006","journal-title":"Kidney Int"},{"key":"pone.0264136.ref062","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/j.ajkd.2003.10.024","article-title":"Pathologic classification of focal segmental glomerulosclerosis: a working proposal","volume":"43","author":"VD D\u2019Agati","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"pone.0264136.ref063","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1038\/s41598-020-63366-0","article-title":"Age-adjusted global glomerulosclerosis predicts renal progression more accurately in patients with IgA nephropathy.","volume":"10","author":"CS Chung","year":"2020","journal-title":"Sci Rep"},{"key":"pone.0264136.ref064","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1089\/ars.2015.6592","article-title":"Vascular smooth muscle-specific EP4 receptor deletion in mice exacerbates angiotensin II-induced renal injury","volume":"25","author":"JF Thibodeau","year":"2016","journal-title":"Antioxid Redox Signal"},{"key":"pone.0264136.ref065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1152\/physiolgenomics.2000.4.1.67","article-title":"Contribution of circulating renin to local synthesis of angiotensin peptides in the heart","volume":"4","author":"G Prescott","year":"2000","journal-title":"Physiol Genomics"},{"key":"pone.0264136.ref066","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1042\/CS20130808","article-title":"Effects of a domain-selective ACE inhibitor in a mouse model of chronic angiotensin II-dependent hypertension","volume":"127","author":"D Burger","year":"2014","journal-title":"Clin Sci"},{"key":"pone.0264136.ref067","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1111\/1440-1681.13384","article-title":"Reversion of cardiovascular remodelling in renovascular hypertensive 2K-1C rats by renin\u2013angiotensin system inhibitors.","volume":"47","author":"JWN Corr\u00eaa","year":"2020","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"pone.0264136.ref068","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MNH.0b013e3282f88a1f","article-title":"Hypertensive nephrosclerosis.","volume":"17","author":"GS Hill","year":"2008","journal-title":"Curr. Opin. Nephrol. Hypertens"},{"key":"pone.0264136.ref069","volume-title":"Heptinstall\u2019s Pathology of the Kidney","author":"JC Jennette","year":"2015","edition":"7"},{"key":"pone.0264136.ref070","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1681\/ASN.2013040371","article-title":"Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression","volume":"25","author":"CE Holterman","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"pone.0264136.ref071","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/ki.2009.168","article-title":"The Oxford classification of IgA nephropathy: Pathology definitions, correlations, and reproducibility","volume":"76","author":"ISD Roberts","year":"2009","journal-title":"Kidney Int"},{"key":"pone.0264136.ref072","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41374-019-0317-7","article-title":"Prostaglandin E2 receptor EP1 (PGE2\/EP1) deletion promotes glomerular podocyte and endothelial cell injury in hypertensive TTRhRen mice.","volume":"100","author":"R Nasrallah","year":"2020","journal-title":"Lab Investig"},{"key":"pone.0264136.ref073","volume-title":"Stereological Methods. Practical methods for biological morphometry.:","author":"ER Weibel","year":"1979"},{"key":"pone.0264136.ref074","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/080370598437286","article-title":"Enhanced angiotensin II stimulates renal disorders in transgenic Tsukuba hypertensive mice","volume":"7","author":"T Kai","year":"1998","journal-title":"Blood Press"},{"key":"pone.0264136.ref075","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3892\/etm.2013.1306","article-title":"Clinical and pathological analysis of the kidney in patients with hypertensive nephropathy.","volume":"6","author":"XC Wang","year":"2013","journal-title":"Exp Ther Med"},{"key":"pone.0264136.ref076","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/TP.0000000000002366","article-title":"A 2018 reference guide to the Banff classification of renal allograft pathology","volume":"102","author":"C Roufosse","year":"2018","journal-title":"Transplantation"},{"key":"pone.0264136.ref077","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41379-018-0154-z","article-title":"Collapsing glomerulopathy in older adults.","volume":"32","author":"B Kukull","year":"2019","journal-title":"Mod Pathol"},{"key":"pone.0264136.ref078","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/MNH.0000000000000596","article-title":"The glomerular crescent: Triggers, evolution, resolution, and implications for therapy.","volume":"29","author":"L Anguiano","year":"2020","journal-title":"Curr. Opin. Nephrol. Hypertens"},{"key":"pone.0264136.ref079","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00428-011-1100-3","article-title":"Afferent arteriolopathy and glomerular collapse but not segmental sclerosis induce tubular atrophy in old spontaneously hypertensive rats.","volume":"459","author":"S Leh","year":"2011","journal-title":"Virchows Arch"},{"key":"pone.0264136.ref080","doi-asserted-by":"crossref","first-page":"e52362","DOI":"10.1371\/journal.pone.0052362","article-title":"The RenTg mice: a powerful tool to study renin-dependent chronic kidney disease.","volume":"7","author":"AC Huby","year":"2012","journal-title":"PLoS One"},{"key":"pone.0264136.ref081","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41581-019-0110-2","article-title":"Macrophages: versatile players in renal inflammation and fibrosis.","author":"PMK Tang","year":"2019","journal-title":"Nat. Rev. Nephrol"},{"key":"pone.0264136.ref082","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1681\/ASN.2011070734","article-title":"Angiotensin II- and salt-induced kidney injury through Rac1-mediated mineralocorticoid receptor activation","volume":"23","author":"W Kawarazaki","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"pone.0264136.ref083","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/HYPERTENSIONAHA.110.163576","article-title":"Inflammation, immunity, and hypertension.","volume":"57","author":"DG Harrison","year":"2011","journal-title":"Hypertension"},{"key":"pone.0264136.ref084","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/sj.ki.5001732","article-title":"Mesangial hypercellularity predicts antiproteinuric response to dual blockade of RAS in primary glomerulonephritis","volume":"70","author":"R Minutolo","year":"2006","journal-title":"Kidney Int"},{"key":"pone.0264136.ref085","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/nm1275","article-title":"Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: A new therapeutic approach","volume":"11","author":"A Lautrette","year":"2005","journal-title":"Nat Med"},{"key":"pone.0264136.ref086","doi-asserted-by":"crossref","first-page":"14448","DOI":"10.1073\/pnas.0703577104","article-title":"Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions","volume":"104","author":"A Advani","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0264136.ref087","first-page":"608512","article-title":"Effect of the antihypertensive drug enalapril on oxidative stress markers and antioxidant enzymes in kidney of spontaneously hypertensive rat","author":"G Chandran","year":"2014","journal-title":"Oxid Med Cell Longev"},{"key":"pone.0264136.ref088","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/01.HYP.0000221605.94532.71","article-title":"Long-term administration of Rho-kinase inhibitor ameliorates renal damage in malignant hypertensive rats","volume":"47","author":"Y Ishikawa","year":"2006","journal-title":"Hypertension"},{"key":"pone.0264136.ref089","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/labinvest.3700052","article-title":"Comparison of renal morphology in the streptozotocin and the SHR\/N-cp models of diabetes","volume":"84","author":"ML Gross","year":"2004","journal-title":"Lab Investig"},{"key":"pone.0264136.ref090","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1523-1755.2004.00406.x","article-title":"Is there an association between level of adult blood pressure and nephron number or renal filtration surface area","volume":"65","author":"MJ Black","year":"2004","journal-title":"Kidney Int"},{"key":"pone.0264136.ref091","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.amjhyper.2004.12.021","article-title":"Glomerular permeability defect in hypertension is dependent on renin angiotensin system activation","volume":"18","author":"R Candido","year":"2005","journal-title":"Am J Hypertens"},{"key":"pone.0264136.ref092","doi-asserted-by":"crossref","first-page":"1","DOI":"10.17352\/aap.000010","article-title":"A comparative morphometric study of the superficial and juxtamedullary nephrons during the postnatal development in spontaneously hypertensive rats","volume":"3","author":"S Stanchev","year":"2018","journal-title":"Arch Anat Physiol"},{"key":"pone.0264136.ref093","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/00004872-199412000-00009","article-title":"Number and size of renal glomeruli in spontaneously hypertensive rats","volume":"12","author":"K Skov","year":"1994","journal-title":"J Hypertens"},{"key":"pone.0264136.ref094","first-page":"107","article-title":"M, Alcorn D, Bertram JF AW. Glomerular dimensions in spontaneously hypertensive rats: effects of AT1 antagonism","volume":"14","author":"M Kett","year":"1996","journal-title":"J Hypertens"},{"key":"pone.0264136.ref095","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1681\/ASN.V1051100","article-title":"Stereologic methods and their application in kidney research","volume":"10","author":"JR Nyengaard","year":"1999","journal-title":"J. Am. Soc. Nephrol"},{"key":"pone.0264136.ref096","doi-asserted-by":"crossref","first-page":"E139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: a report from the American Heart Association","volume":"141","author":"SS Virani","year":"2020","journal-title":"Circulation"},{"key":"pone.0264136.ref097","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1681\/ASN.V981399","article-title":"Progressive glomerular injury in the MWF rat is predicted by inborn nephron deficit","volume":"9","author":"AM Fassi","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"pone.0264136.ref098","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1681\/ASN.2014100971","article-title":"Regression of renal disease by angiotensin II antagonism is caused by regeneration of kidney vasculature","volume":"27","author":"A Remuzzi","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"pone.0264136.ref099","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1046\/j.1523-1755.2002.00354.x","article-title":"Chronic anti-Thy-1 nephritis is aggravated in the nonclipped but not in the clipped kidney of Goldblatt hypertensive rats","volume":"61","author":"UO Wenzel","year":"2002","journal-title":"Kidney Int"},{"key":"pone.0264136.ref100","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/HJH.0b013e32835a5d4e","article-title":"Arterial damage precedes the development of interstitial damage in the nonclipped kidney of two-kidney, one-clip hypertensive rats","volume":"31","author":"T Skogstrand","year":"2013","journal-title":"J Hypertens"},{"key":"pone.0264136.ref101","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0895-7061(02)03266-1","article-title":"Differential regulation of osteopontin expression in the clipped and nonclipped kidney of two-kidney, one-clip hypertensive rats","volume":"16","author":"S Gauer","year":"2003","journal-title":"Am J Hypertens"},{"key":"pone.0264136.ref102","doi-asserted-by":"crossref","first-page":"F293","DOI":"10.1152\/ajprenal.00319.2004","article-title":"The renal vascular response to ANG II injection is reduced in the nonclipped kidney of two-kidney, one-clip hypertension","volume":"289","author":"LM Bivol","year":"2005","journal-title":"Am J Physiol Ren Physiol"},{"key":"pone.0264136.ref103","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1084\/jem.59.3.347","article-title":"Studies on experimental hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal iscttemia","volume":"59","author":"H Goldblatt","year":"1934","journal-title":"J Exp Med"},{"key":"pone.0264136.ref104","first-page":"545","article-title":"Metaplastic and mitotic activity of the ischemic (endocrine) kidney in experimental renal hypertension.","volume":"96","author":"M Cantin","year":"1979","journal-title":"Am J Pathol"},{"key":"pone.0264136.ref105","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/01.HYP.29.4.1025","article-title":"Two-kidney, one clip and one-kidney, one clip hypertension in mice","volume":"29","author":"P Wiesel","year":"1997","journal-title":"Hypertension"},{"key":"pone.0264136.ref106","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1152\/japplphysiol.01015.2011","article-title":"A novel vascular clip design for the reliable induction of 2-kidney, 1-clip hypertension in the rat","volume":"112","author":"SP Chelko","year":"2012","journal-title":"J Appl Physiol. (1985)"},{"key":"pone.0264136.ref107","doi-asserted-by":"crossref","first-page":"e0216734","DOI":"10.1371\/journal.pone.0216734","article-title":"A novel method for comparison of arterial remodeling in hypertension: Quantification of arterial trees and recognition of remodeling patterns on histological sections","volume":"14","author":"AA Gutsol","year":"2019","journal-title":"PLoS One"},{"key":"pone.0264136.ref108","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1291\/hypres.31.873","article-title":"Vascular permeability, blood pressure, and organ damage in primary hypertension.","volume":"31","author":"F Viazzi","year":"2008","journal-title":"Hypertens Res"},{"key":"pone.0264136.ref109","doi-asserted-by":"crossref","first-page":"F790","DOI":"10.1152\/ajprenal.00153.2012","article-title":"Rapid, dynamic changes in glomerular permeability to macromolecules during systemic angiotensin II (ANG II) infusion in rats.","volume":"303","author":"J Axelsson","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"pone.0264136.ref110","doi-asserted-by":"crossref","first-page":"e113459","DOI":"10.1371\/journal.pone.0113459","article-title":"A novel mouse model of advanced diabetic kidney disease.","volume":"9","author":"JF Thibodeau","year":"2014","journal-title":"PLoS One"},{"key":"pone.0264136.ref111","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev.pathol.1.110304.100119","article-title":"Pathogenesis of nonimmune glomeralopathies.","volume":"1","author":"C Kwoh","year":"2006","journal-title":"Annu. Rev. Pathol"},{"key":"pone.0264136.ref112","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1681\/ASN.2012020187","article-title":"IgM contributes to glomerular injury in FSGS","volume":"24","author":"D Strassheim","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"pone.0264136.ref113","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3325\/cmj.2017.58.281","article-title":"IgM as a novel predictor of disease progression in secondary focal segmental glomerulosclerosis.","volume":"58","author":"A Pa\u010di\u0107","year":"2017","journal-title":"Croat Med J."},{"key":"pone.0264136.ref114","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1681\/ASN.2018020184","article-title":"C5b9 formation on endothelial cells reflects complement defects among patients with renal thrombotic microangiopathy and severe hypertension","volume":"29","author":"S Timmermans","year":"2018","journal-title":"J Am Soc Nephrol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0264136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T18:46:12Z","timestamp":1645123572000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0264136"}},"subtitle":[],"editor":[{"given":"Jaap A.","family":"Joles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":114,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0264136","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,17]]}}}